NCT03821142View on ClinicalTrials.gov

Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair

NAActive, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2029

Conditions
Pelvic Organ Prolapse
Interventions
DEVICE

Transvaginal mesh for anterior pelvic organ prolapse repair

synthetic mesh for anterior pelvic organ prolapse with or without apical vaginal wall involvement via the vaginal route in a highly selected patient population

Trial Locations (6)

Unknown

Helios Hospital Erfurt, Department of gynaecology, Erfurt

St. Hedwig Hospital, Berlin

Evangelic Diakonie Hospital, Freiburg im Breisgau

St. Elisabeth-Hospital Leipzig, Leipzig

Hospital Tettnang, Tettnang

University Hospital Tübingen, Tübingen

All Listed Sponsors
lead

Promedon

INDUSTRY